Laman UtamaRIG2 • FRA
add
Gedeon Richter Ord Shs
Tutup sebelumnya
€25.60
Julat hari
€26.14 - €26.50
Julat tahun
€22.94 - €28.32
Bilangan Purata
506.00
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(HUF) | Mac 2025info | Perubahan T/T |
---|---|---|
Hasil | 224.02B | 10.12% |
Perbelanjaan pengendalian | 87.41B | 11.22% |
Pendapatan bersih | 68.14B | -0.11% |
Margin untung bersih | 30.42 | -9.28% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 81.81B | 8.83% |
Kadar cukai berkesan | 16.84% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(HUF) | Mac 2025info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 201.78B | 97.83% |
Jumlah aset | 1.63T | 14.46% |
Jumlah liabiliti | 282.79B | 26.01% |
Jumlah ekuiti | 1.35T | — |
Syer tertunggak | 182.68J | — |
Harga kepada buku | 0.00 | — |
Pulangan pada aset | 10.49% | — |
Pulangan pada modal | 11.96% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(HUF) | Mac 2025info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 68.14B | -0.11% |
Tunai daripada operasi | 63.41B | 10.41% |
Tunai daripada pelaburan | 5.42B | 114.85% |
Tunai daripada pembiayaan | -1.70B | 78.15% |
Perubahan bersih dalam tunai | 65.38B | 380.67% |
Aliran tunai bebas | 3.87B | -86.71% |
Perihal
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
CEO
Diasaskan
1901
Tapak web
Pekerja
10,943